Johan H. van Es
- Oncology top 0.02%
- Cancer Cells and Metastasis 34
- Molecular Biology top 0.05%
- Wnt/β-catenin signaling in development and cancer 33
- Cancer-related gene regulation 17
- Epigenetics and DNA Methylation 17
- Cancer Research top 0.1%
- Genetics top 0.05%
- Digestive system and related health 22
- Hepatology top 0.5%
-
- Pancreatic function and diabetes 15
-
- Venous Thromboembolism Diagnosis and Management 12
-
- Monoclonal and Polyclonal Antibodies Research 9
- Co-authors
- Hans CleversNick BarkerMaaike van den BornMarc van de WeteringDaniel E. StangeToshiro SatoHugo J.G. SnippertPeter J. Peters
- Partner nations
- NetherlandsUnited StatesUnited Kingdom
In The Last Decade
Johan H. van Es
124 papers receiving 41.0k citations
Hit Papers
Peers
Comparison fields: 5 of 166
- Oncology 17.7k
- Molecular Biology 23.1k
- Cancer Research 4.6k
- Genetics 8.0k
- Hepatology 2.0k
Countries citing papers authored by Johan H. van Es
This map shows the geographic impact of Johan H. van Es's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Johan H. van Es with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Johan H. van Es more than expected).
Fields of papers citing papers by Johan H. van Es
This network shows the impact of papers produced by Johan H. van Es. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Johan H. van Es. The network helps show where Johan H. van Es may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Johan H. van Es, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2026 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 0 | |
| 4 | 2024 | 5 | |
| 5 | 2024 | 8 | |
| 6 | 2024 | 9 | |
| 7 | 2023 | 21 | |
| 8 | 2023 | 32 | |
| 9 | 2020 | 27 | |
| 10 | 2018 | 121 | |
| 11 | 2018 | 147 | |
| 12 | 2016 | 206 | |
| 13 | 2015 | 126 | |
| 14 | Risk profile and clinical outcome of symptomatic isolated subsegmental pulmonary embolism | 2013 | 0 |
| 15 | Clinical impact of findings supporting an alternative diagnosis on computed tomography pulmonary angiography in patients with suspected pulmonary embolism | 2013 | 1 |
| 16 | 2013 | 85 | |
| 17 | Lineage Tracing Reveals Lgr5 + Stem Cell Activity in Mouse Intestinal Adenomasbreakdown → | 2012 | 822 |
| 18 | Lgr6 Marks Stem Cells in the Hair Follicle That Generate All Cell Lineages of the Skinbreakdown → | 2010 | 585 |
| 19 | Transcription Factor Achaete Scute-Like 2 Controls Intestinal Stem Cell Fatebreakdown → | 2009 | 546 |
| 20 | 2001 | 108 |
About Johan H. van Es
Johan H. van Es is a scholar working on Internal Medicine, Oncology and Genetics, having authored 131 papers that have together received 41.4k indexed citations. Recurring topics across this work include Cancer Cells and Metastasis (34 papers), Wnt/β-catenin signaling in development and cancer (33 papers), Digestive system and related health (22 papers), Cancer-related gene regulation (17 papers), Epigenetics and DNA Methylation (17 papers), Pancreatic function and diabetes (15 papers), Venous Thromboembolism Diagnosis and Management (12 papers) and Monoclonal and Polyclonal Antibodies Research (9 papers). The work is most often cited by research in Oncology (17.7k citations), Molecular Biology (23.1k citations) and Cancer Research (4.6k citations). Johan H. van Es has collaborated with scholars based in Netherlands, United States and United Kingdom. Frequent co-authors include Hans Clevers, Nick Barker, Maaike van den Born, Marc van de Wetering, Daniel E. Stange, Toshiro Sato, Hugo J.G. Snippert, Peter J. Peters, Harry Begthel and Pekka Kujala. Their work appears in journals such as Nature, Proceedings of the National Academy of Sciences, Cell, Cell stem cell and Science.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.